Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-29 @ 8:30 PM
Study NCT ID:
NCT00479856
Status:
TERMINATED
Last Update Posted:
2012-06-05
First Post:
2007-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EGF108916
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None